Accessibility Menu
Amexdrug logo

Amexdrug(OTC) AXRX

Market Cap$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1985)-100%
5 Year-100%
1 Year+100%
1 Month+0%
$0.00
+0.00%
+0.00Today
Amexdrug last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-10
Amexdrug stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-05-12
1 month+0%USD 0.002026-05-12
3 month+0%USD 0.002025-12-19
Year to date+0%USD 0.002025-12-19
1 year+100%USD 0.002025-06-06
3 year-80%USD 0.002023-06-12
5 year-99.83%USD 0.122021-06-08
Since inception-100%USD 25.001985-12-17

Amexdrug Financials at a Glance

Market Cap

$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.87M

Net Income (TTM)

$45.69K

EPS (TTM)

$0.00

P/E Ratio

0.67

Dividend

$0.00

Beta (Volatility)

23.63 (High)

Price

$0.00

Volume

2,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

AXRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amexdrug

Amexdrug Corporation is a pharmaceutical and cosmeceutical enterprise based in Commerce, California. Established in 1963, the company specializes in the distribution of pharmaceutical products and is involved in the entire lifecycle of drugs, cosmetics, and medical devices.

Products and Services
  • Distribution of prescription and over-the-counter medications
  • Manufacturing of health and beauty products under the Sponix brand
  • Private manufacturing and labeling services
Growth Outlook
  • Recent quarterly revenue reached $736,558, showing a positive trend
  • Gross profit margin improved to 55.5% in the latest quarter
  • Current ratio stands at 15.3, indicating strong liquidity
Financial Highlights
  • Net income of $20,973 reported for the latest quarter
  • Trailing twelve months (TTM) P/E ratio at 0.4, suggesting potential value
  • Cash and short-term investments total $1,674,200, providing financial stability
AI Generated • Jul 7, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Jack N. Amin

Website

www.amexdrug.com

Headquarters

Commerce, CA 90040, US

AXRX Financials

Key Financial Metrics (TTM)

Gross Margin

38.48%

Operating Margin

5.29%

Net Income Margin

1.59%

Return on Equity

2.52%

Return on Capital

6.12%

Return on Assets

1.90%

Earnings Yield

1.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

169.41M

Volume

2.20K

Avg. Volume

103.603

Financials (TTM)

Gross Profit

$1.11M

Operating Income

$151.89K

EBITDA

$151.89K

Operating Cash Flow

$146.60

Capital Expenditure

$0.00

Free Cash Flow

$146.60

Cash & ST Invst.

$1.67M

Total Debt

$422.55K

Amexdrug Performance Analysis

Amexdrug annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 4,822,371N/A
20232023-12-31USD 3,915,257-18.8%
20242024-12-31USD 3,398,631-13.2%
20252025-12-31USD 2,902,241-14.6%
Amexdrug sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-1.7%
Q32025-09-30-10.0%
Q42025-12-313.1%
Q12026-03-315.1%
Amexdrug annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.04N/A
20232023-12-31USD 0.00-99.5%
20242024-12-31USD 0.00-50.0%
20252025-12-31USD 0.00100.0%
Amexdrug sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30100.0%
Q32025-09-30-50.0%
Q42025-12-31N/A
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$736.56K

-4.0%

Gross Profit

$408.96K

-9.8%

Gross Margin

55.52%

N/A

Market Cap

$33.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.77K

N/A

Employees

9

N/A

Net Income

$20.97K

+34.8%

EBITDA

$47.37K

+46.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.67M

+9.6%

Total Debt

$422.55K

+7.9%

Accounts Receivable

$37.49K

-76.9%

Inventory

$554.36K

-5.5%

Long Term Debt

$422.55K

+7.9%

Short Term Debt

$0.00

N/A

Return on Assets

1.90%

N/A

Return on Invested Capital

6.76%

N/A

Free Cash Flow

$146.60

N/A

Operating Cash Flow

$146.60

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WSRCWestern Sierra Resource Corporation
$0.00+0.00%
NSRSNorth Springs Resources Corp
$0.00+0.00%
PSIQProfile Solutions, Inc.
$0.00+0.00%
RLBDReal Brands, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About AXRX

What is the current price of Amexdrug?

Amexdrug is trading at $0.00 per share.

What is the 52-week range for Amexdrug?

Over the past 52 weeks, Amexdrug has traded between $0.00 and $0.00.

How much debt does Amexdrug have?

As of the most recent reporting period, Amexdrug reported total debt of $422.55K.

How much cash does Amexdrug have on hand?

Amexdrug reported $57.53K in cash and cash equivalents in its most recent financial results.

What is Amexdrug’s dividend yield?

Amexdrug does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services